Baker McKenzie advised CureVac on the deal. CureVac N.V., a global biopharmaceutical company developing transformative medicines based on messenger ribonucleic acid (mRNA), restructured its existing collaboration...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised CureVac N.V. on the deal. CureVac N.V., a global biopharmaceutical company developing transformative medicines based on messenger ribonucleic acid (mRNA), entered into a...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Sumitomo Rubber Industries, Ltd. on the deal. Sumitomo Rubber Industries concluded an agreement to assign all shares it holds in Lonstroff AG to...
You must be a Standard 1 Year member to access this content.
Baker McKenzie Switzerland advised Argos Wityu on all legal aspects of the transaction. Argos Wityu executed the acquisition of the majority stake in Norline AG, a leading...
You must be a Standard 1 Year member to access this content.
Baker McKenzie, Marek Partners and Divjak Topic Bahtijarevic & Krka advised Migros-Genossenschafts-Bund and its start-up incubator Sparrow Ventures on the deal. Bär & Karrer advised the...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Avrios International AG on the deal. Avrios International AG and its shareholders executed the sale of all equity interests in Avrios to US...
You must be a Standard 1 Year member to access this content.
Baker McKenzie assisted Transcom on the deal alongside in-house Legal Manager Francesco Laureti. Transcom, a global customer experience specialist, announced the acquisition of Forcontact, a customer...
You must be a Standard 1 Year member to access this content.
